Q4 2018 Investor Presentation

Why Invest? - Driving Long-Term Shareholder Value لا Market Dynamics Underpenetrated markets in sleep & COPD • Healthcare costs continue to increase • Focus on improving patient outcomes • Value-based . technology solutions Growth & Innovation Global leader in connected health for sleep and respiratory care Long-term growth opportunities 5,500+ patents and designs - 7% of revenue invested in R&D Financial Results • Historical revenue and • profit growth Recurring revenue Operating excellence program Strong track record of disciplined capital deployment © 2018 ResMed I Q4 2018 Investor Presentation | 5 ResMed

View entire presentation